2023
|
Question
[CLICK ON ANY CHOICE TO KNOW THE RIGHT ANSWER]
|
Which of the following has announced an agreement with Laxai Life Sciences Pvt. Ltd. to co-develop SARS-CoV-2 Main Proteases inhibitors for the treatment of COVID-19?
|
|
Piramal Group
|
|
|
Indian Immunologicals Ltd
|
|
|
Transasia Bio-Medicals
|
|
|
A2A Pharmaceuticals
|
Explanation:
There is 1 question to complete.